Deise Uema

Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study

Myung‐Ju Ahn, Kentaro Tanaka, Luis Paz‐Ares et al. · Journal of Clinical Oncology · 2024 · 182 citations · Full text

Medicine, Oncology, Pharmacology +9

PL02.11 Normalized Membrane Ratio of TROP2 by Quantitative Continuous Scoring is Predictive of Clinical Outcomes in TROPION-Lung 01

M.C. Garassino, J. Sands, Luis Paz‐Ares et al. · Journal of Thoracic Oncology · 2024 · 71 citations · Full text

Medicine, Cell Biology, Clinical Sciences +2

LBA12 Datopotamab deruxtecan (Dato-DXd) vs docetaxel in previously treated advanced/metastatic (adv/met) non-small cell lung cancer (NSCLC): Results of the randomized phase III study TROPION-Lung01

M-J. Ahn, Aaron Lisberg, Luis Paz‐Ares et al. · Annals of Oncology · 2023 · 55 citations · Full text

Medicine, Oncology, Pharmacology +12

Carcinoid Heart Disease and Decreased Overall Survival among Patients with Neuroendocrine Tumors: A Retrospective Multicenter Latin American Cohort Study

Deise Uema, Carolina Alves, Marcella Coelho Mesquita et al. · Journal of Clinical Medicine · 2019 · 19 citations · Full text

Medicine, Cardiology, Oncology +11

Validation of questionnaire on the Spiritual Needs Assessment for Patients (SNAP) questionnaire in Brazilian Portuguese

Diego de Araujo Toloi, Deise Uema, Felipe Yu Matsushita et al. · ecancermedicalscience · 2016 · 15 citations · Full text

Nursing, Oncology, Translation Studies +15